Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Rosuvastatin on Endothelial Function in Patients with Diabetes and Glaucoma
2008-006937-28Phase 4Terminated
- Sponsor
- Department of Clinical Pharmacology, Medical University of Vienna
- Start
- Nov 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of rosuvastatin in diabetes mellitus type 1 (T1D), type 2 diabetes mellitus (T2DM) and Glaucoma, sponsored by Department of Clinical Pharmacology, Medical University of Vienna. Primary endpoint: Endothelial function at 12 weeks. Started Nov 2008; status: terminated.
02
Drugs
rosuvastatin
03
Conditions
diabetes mellitus type 1 (T1D)type 2 diabetes mellitus (T2DM)Glaucoma
Beyond the preview
Go deeper on 2008-006937-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006937-28.